Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the market grown in recent years?
In the past few years, the market size for ventral hernia treatment has seen substantial growth. Its projected growth is from $4.87 billion in 2024 to $5.23 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.5%. Factors such as the growing incidence of obesity, heightened awareness about ventral hernias, an aging population, an increase in disposable income, and the rising demand for less invasive surgical procedures played a significant role in this historic period of growth.
How is the market size expected to evolve during the forecast period?
The market size for ventral hernia treatment is anticipated to experience considerable growth in the upcoming years. By 2029, it is predicted to reach $6.90 billion, with a compound annual growth rate (CAGR) of 7.2%. This expansion in the forecast period is due to the escalating demand for outpatient procedures, heightened healthcare expenditure, increasing government initiatives, growing demand for hernia repair operations, and enhanced funding in research and development. Noteworthy trends during the forecast period encompass innovative hernia repair devices, bioabsorbable materials, strategic partnership efforts, robot-assisted surgical appliances, and remote patient monitoring.
Get your market report here!
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report
What are the leading drivers of growth in the market?
The escalating frequency of obesity is projected to drive the expansion of the ventral hernia treatment market. Obesity, characterized by excessive body fat, significantly affects a person’s health condition. It can be attributed to poor dietary habits, a sedentary lifestyle, genetic predispositions, lack of exercise, environmental factors, and emotional stress. Ventral hernia treatments assist individuals with obesity by addressing complications linked to excessive weight. Such treatments aid in reducing pressure on the abdominal wall, lessen the possibility of hernia relapse, and improve overall stomach strength, which is vital for enhancing mobility and encouraging healthier lifestyle choices among individuals dealing with obesity. For instance, in March 2024, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported that nearly one-eighth of the global population struggled with obesity. This included 2.5 billion adults (18 years and above) being overweight, with 890 million living with obesity. Among these adults, 43% were overweight and 16% were deemed obese. Besides, the under-five overweight children population reached 37 million. Consequently, the rise in obesity rates is fueling the ventral hernia treatment market.
What are the market segments in the industry?
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp
Which leading companies are shaping the growth of the market?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.
What are the key trends shaping the future of the market?
The key players in the ventral hernia treatment market are concentrating on technological enhancements such as open and laparoscopic hernia mesh fixation devices. These advancements are aimed at augmenting surgery results, minimizing complications, and accelerating patient recovery. The open and laparoscopic hernia mesh fixation devices are specialized tools used in hernia repair surgeries for securing the mesh through either minimally invasive (laparoscopic) techniques or the traditional open surgery methods. For example, TELA Bio Inc., a medical technology firm based in the U.S., released the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. in March 2024. The LIQUIFIX FIX8 is purposed for minimally invasive repairs whereas LIQUIFIX precision is intended for open femoral and inguinal hernia repairs. These FDA-endorsed devices employ liquid anchors for mesh attachment without tissue penetration, subsequently minimising trauma and complications. Considering the annual rate of over 1.2 million hernia procedures in the U.S., LIQUIFIX offers safety and precision in delicate areas and reduces the chances of vascular or nerve damage.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315
Which geographic areas are influencing the growth of the market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Pneumococcal Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
Travel Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Vaccine Contract Manufacturing Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
